Zacharias et al. supported this claim in non-small cell lung cancer (NSCLC) patient samples, where they found CXCR1+ staining in all samples, while CXCR2 was only expressed in a few tumor samples [84]. The gene discussed is CXCR1; the disease is neoplasm.